Dabigatran-induced esophagitis.

Clin Gastroenterol Hepatol

Department of Gastroenterology and GI Endoscopy Center, Shin-Kokura Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Kitakyushu, Japan.

Published: July 2014

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2013.09.010DOI Listing

Publication Analysis

Top Keywords

dabigatran-induced esophagitis
4
dabigatran-induced
1

Similar Publications

Unlabelled: Dabigatran, a commonly prescribed anticoagulant medication, has been associated with esophagitis, referred to as dabigatran-induced esophagitis (DIE). We report a case of DIE occurring in a patient following left atrial ablation for atrial fibrillation. This case emphasizes the importance of recognizing the possible combined detrimental effects of left atrial ablation and dabigatran on the esophageal mucosa and highlights the clinical and endoscopic characteristics associated with DIE.

View Article and Find Full Text PDF

Dabigatran is a useful and widely used drug for stroke prevention in patients with atrial fibrillation. However, it has been reported to cause esophagitis. Herein, we report the case of a 77-year-old man with dabigatran-induced esophagitis with blue pigmentation, which is known to be a rare adverse effect.

View Article and Find Full Text PDF

Analysis of the clinical characteristics of dabigatran-induced oesophagitis.

Eur J Hosp Pharm

March 2023

Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China

Objectives: Dabigatran-induced oesophagitis has emerged in recent years. However, the incidence and clinical characteristics of patients with dabigatran-induced oesophagitis have not yet been clarified. The aim of this study was to examine the clinical characteristics of the disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!